CH Biotech R&D Valuation

Is 6534 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6534 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6534 (NT$82.9) is trading above our estimate of fair value (NT$22.24)

Significantly Below Fair Value: 6534 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6534?

Key metric: As 6534 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 6534. This is calculated by dividing 6534's market cap by their current earnings.
What is 6534's PE Ratio?
PE Ratio	22.4x
Earnings	NT$381.23m
Market Cap	NT$8.52b

6534 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.8x
Enterprise Value/EBITDA	13.6x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 6534's PE Ratio compare to its peers?

The above table shows the PE ratio for 6534 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	22.2x
1708 Sesoda	12.2x	n/a	NT$10.7b
1712 Sinon	18.7x	n/a	NT$19.1b
4148 All Cosmos Bio-Tech Holding	32.7x	n/a	NT$3.3b
6508 Huikwang	25.3x	n/a	NT$2.6b
6534 CH Biotech R&D	22.4x	n/a	NT$8.5b

Price-To-Earnings vs Peers: 6534 is expensive based on its Price-To-Earnings Ratio (22.4x) compared to the peer average (22.2x).

Price to Earnings Ratio vs Industry

How does 6534's PE Ratio compare vs other companies in the TW Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 6534 is good value based on its Price-To-Earnings Ratio (22.4x) compared to the TW Chemicals industry average (22.4x).

Price to Earnings Ratio vs Fair Ratio

What is 6534's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6534 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	22.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6534's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

China General Plastics

NT$8.5b

Engages in the manufacture and marketing of petrochemical products in Asia, America, the Middle East, Europe, Africa, and Oceania.

1305

NT$14.65

-2.7%

-37.5%

Sesoda

NT$10.7b

Manufactures and markets sulfate of potash (SOP) in Taiwan.

1708

NT$43.05

-0.3%

33.5%

Lucky Cement

NT$5.9b

Manufactures and sells cement in the People’s Republic of China.

1108

NT$14.55

0.7%

-3.6%